How They Won It: Kaye, Munger Ward Off Pay-For-Delay Case

By Melissa Lipman (March 11, 2014, 8:37 PM EDT) -- To shut down a pay-for-delay class action against Pfizer Inc.'s King Pharmaceuticals Inc. and generic-drug maker Mutual Pharmaceutical Co. Inc., attorneys from Kaye Scholer LLP and Munger Tolles & Olson LLP had to figure out how to explain why the U.S. drug distribution system didn't fit the traditional antitrust class certification model. For the defense team, that meant leading with a complex economic story and trusting the judge to come along for the ride....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!